Application of PK-PD Modeling in Understanding Bystander Effect for Antibody Drug Conjugates

被引：0
|
作者：
Singh, Aman P. [1 ]
Shah, Dhaval K. [1 ]
机构：
[1] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-041
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Understanding and Characterizing the Bystander Effect for Antibody Drug Conjugates
    Singh, Aman P.
    Sharma, Sharad
    Shah, Dhaval K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S12 - S13
  • [2] IMPACT OF QUANTITATIVE PK-PD MODELING IN BIOLOGICS DRUG DISCOVERY
    Garg, Amit
    DRUG METABOLISM REVIEWS, 2012, 44 : 6 - 6
  • [3] Physiologically-Based PK/PD Modeling for Oncology: Applications for Antibody Drug Conjugates
    Block, Michael
    Burghaus, Rolf
    Dickschen, Kristin
    Gaub, Thomas
    Kuepfer, Lars
    Lippert, Joerg
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S58 - S59
  • [4] Translational PK-PD modeling in pain
    Yassen, Ashraf
    Passier, Paul
    Furuichi, Yasuhisa
    Dahan, Albert
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (03) : 401 - 418
  • [5] Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1)
    Singh, Aman P.
    Shah, Dhaval K.
    AAPS JOURNAL, 2017, 19 (04): : 1054 - 1070
  • [6] Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1)
    Aman P. Singh
    Dhaval K. Shah
    The AAPS Journal, 2017, 19 : 1054 - 1070
  • [7] Bystander effect of antibody–drug conjugates: fact or fiction?
    Federica Giugliano
    Chiara Corti
    Paolo Tarantino
    Flavia Michelini
    Giuseppe Curigliano
    Current Oncology Reports, 2022, 24 : 809 - 817
  • [8] Integration of bioanalytical measurements using PK-PD modeling and simulation: implications for antibody-drug conjugate development
    Khot, Antari
    Sharma, Sharad
    Shah, Dhaval K.
    BIOANALYSIS, 2015, 7 (13) : 1633 - 1648
  • [9] PK-PD integration and modeling of marbofloxacin in sheep
    Sidhu, P. K.
    Landoni, M. F.
    Aliabadi, F. S.
    Lees, P.
    RESEARCH IN VETERINARY SCIENCE, 2010, 88 (01) : 134 - 141
  • [10] Relating tumor drug concentrations to target effect with semi physiologic PK-PD modeling in drug development: An application using a novel dCK inhibitor
    Poddar, Soumya
    Nikanjam, Mina
    Capparelli, Edmund
    Thuc Le
    Wei, Liu
    Radu, Caius
    CANCER RESEARCH, 2019, 79 (13)
12345